DAILYZ HEALTH NEWS

September 13, 2026 Evan Vega

CDC and state health officials investigate multistate Listeria outbreak linked to soft-ripened cheese sold at Whole Foods Market, prompting nationwide recall and public warning to high-risk consumers

CDC and state officials investigated a 2013 multistate Listeria outbreak linked to Crave Brothers soft-ripened cheeses sold at Whole Foods, leading to a recall.

Health

August 29, 2026 Evan Vega

FDA Approves Roivant’s Lisraya (brepocitinib) as First Oral Drug for Dermatomyositis

The FDA approved Roivant’s Lisraya (brepocitinib), the first oral dual TYK2/JAK1 inhibitor, to treat dermatomyositis in adults.

Health

August 28, 2026 Evan Vega

FDA Recalls 12 Herbal Supplements Over Hidden Drug Ingredients

GURU INC. recalled Infla-650 herbal supplement after FDA found undeclared drugs acetaminophen, diclofenac, and phenylbutazone in the capsules.

Health

August 27, 2026 Evan Vega

Pennsylvania records its first measles deaths in 35 years

Pennsylvania reports its first measles deaths in 35 years, with two unvaccinated individuals dying amid a 393-case outbreak in 29 counties.

Health

August 27, 2026 Evan Vega

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

The FDA approved LISRAYA (brepocitinib), the first oral TYK2/JAK1 inhibitor for treating adult dermatomyositis, on August 27, 2026.

Health

August 22, 2026 Evan Vega

FDA Elevates Massive Egg Recall to Highest-Risk Salmonella Warning

The FDA upgraded the recall of 1.6 million Midwest Poultry eggs to Class I due to a multistate Salmonella Enteritidis outbreak in 2026.

Health

August 22, 2026 Evan Vega

Atrium Health Commits More Than $700 Million in Partnership with Morehouse School of Medicine

Atrium Health partners with Morehouse School of Medicine, investing over $700 million to build a new hospital and expand healthcare in South and West Atlanta.

Health

August 22, 2026 Evan Vega

OHSU-Led Study Finds Psilocybin Safe and Effective for Mood Disorders in 2,300 Real-World Users

OHSU study finds psilocybin safe and effective for treating mood disorders in over 2,300 users in Oregon’s real-world settings.

Health

August 20, 2026 Evan Vega

Rare disease drug recalled in Ireland after deaths in Japan

Irish authorities recalled the rare disease drug Tavneos after reports of about 20 deaths linked to liver dysfunction in Japan since 2022.

Health

August 20, 2026 Evan Vega

FDA approves new imaging agent for Alzheimer’s disease detection

The FDA approved Tauklarify, a tau PET imaging agent, for detecting tau pathology in adults evaluated for Alzheimer’s disease.

DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

CDC and state health officials investigate multistate Listeria outbreak linked to soft-ripened cheese sold at Whole Foods Market, prompting nationwide recall and public warning to high-risk consumers

FDA Approves Roivant’s Lisraya (brepocitinib) as First Oral Drug for Dermatomyositis

FDA Recalls 12 Herbal Supplements Over Hidden Drug Ingredients

Pennsylvania records its first measles deaths in 35 years

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

FDA Elevates Massive Egg Recall to Highest-Risk Salmonella Warning

Atrium Health Commits More Than $700 Million in Partnership with Morehouse School of Medicine

OHSU-Led Study Finds Psilocybin Safe and Effective for Mood Disorders in 2,300 Real-World Users

Rare disease drug recalled in Ireland after deaths in Japan

FDA approves new imaging agent for Alzheimer’s disease detection